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in minutes (each the average of three simultaneous bleeding-
times) were as follows:
We were thus able to confirm Professor Quick’s observation
that aspirin slightly prolongs the bleeding-time in normal
persons, but we also noted a similar but less significant trend
with sodium salicylate. The difference in results may be
because we used the Ivy rather than the Duke technique to
determine the bleeding-time or because we administered a
larger dose of sodium salicylate in an attempt to equate its
pharmacological effect with that of aspirin. Our results sug-
gest that it is too early to implicate the acetyl group as the
cause of the prolonged bleeding-time.
We hope to extend our observations to a larger series of subjects
and to observe the effect of these drugs on physiological functions
which may control the bleeding-time in normal persons and patients
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SERUM-URIC-ACID LEVELS
SIR,-The population of New Haven, Connecticut, seems to
have a most extraordinary characteristic according to Professor
Acheson and Dr. O’Brien (Oct. 8, p. 777). We have reviewed
the published reports on uric-acid levels in reasonably repre-
sentative samples of the Caucasian population from the U.K.,
the U.S., and Denmark. (Blood-donors are not considered
representative samples.) Among the seven thoroughly com-
petent reports for which the determinations were done by the
spectrophotometric uricase method there are no instances in
which the mean serum-uric-acid level was above 5-2 mg. per
100 ml. in males or 4-0 mg. per 100 ml. in females; yet according
to Professor Acheson and Dr. O’Brien in New Haven the mean
for males is 6-4 mg. per 100 ml. and for females 4-7 mg. per
100 ml.-i.e., about 62 and 45 respectively after correcting
for the bias of their method. Why are the levels so high in
New Haven, and why is the difference between males and
females so much greater than in other Caucasian populations ?
Is it possible that the mean uric-acid levels should be this high
without a substantial excess of gout in the community ? All
these rather striking points are passed without comment.
The preliminary communication of Professor Acheson and
Dr. O’Brien focuses on certain " physique " variables.
Specifically, they note that about 4&deg;n of uric-acid variance is
accounted for by haemoglobin level, and about 15 &deg;, of the
variance is accounted for by multiple regression with ha:mo-
globin and either body-weight or ponderal index. Then they
suggest that the correlation of serum-uric-acid (S.U.A.) and
achievement-oriented behaviour (A.o.B.) noted by Brooks and
Mueller might be substantially altered if these physique
variables are partialled out. The direction and degree of
such alteration depends, of course, on the association between
obesity and A.o.B., which was not reported by Brooks and
Mueller. Given the correlations S.U.A. to A.O.B. = 0,66 and
S.U.A. to obesity = 0,26, no matter what the correlation of
obesity to A.o.B. the minimum partial correlation of S.U.A. to
A.o.B., holding obesity constant, would be about 0.62, but
would 0-68 among university professors, in whom the correla-
tion of obesity to A.o.B. is 0,00.
At this point it is premature to discuss whether total body-
weight, lean body-weight, degree of obesity, or ponderal index
is the most relevant variable for understanding uric-acid levels.
But it is important to recognise that present evidence suggests
that these variables will partial out at most only a trivial
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’*’ ’*’ A copy of this letter was sent by Dr. Cobb and his
colleagues to Professor Acheson and Dr. O’Brien, whose reply
follows.-ED. L.
SIR,-As Dr. Cobb well knows we are as intrigued as he at
the high levels of serum-uric-acid in New Haven, and as our
survey continues we hope will learn more of their cause. At this
juncture, we can only repeat that we took the trouble to run
repeated double-blind comparative analyses with another
laboratory which we also believe to be " thoroughly com-
petent ". As we stated in our paper the results from the two
laboratories differed a little in their mean values, but they
correlated very highly.
It is at best hazardous to attempt to deduce " obesity " from
weight, whether or not it is corrected for height, especially in
males: we prefer the term " body bulk ". Be that as it may,
our regressions indicate that an " average man " of 150 lb.
(lOst. 10 lb.) with a hxmoglobin of 13-0 g. per 100 ml. will have
a uric acid of 5-5 mg. per 100 ml., and one of 250lb. (17 st. 121b.)
with a hxmoglobin of 17-0 g. per 100 ml. will have a uric acid
of 7-3 mg. per 100 ml. These not too outrageous values can be
calculated directly from our published data. It is not possible
to make any direct calculation of the relation of 
" obesity "-
or of any other measure of body bulk-to serum-uric-acid,
from the published work of Brooks and Mueller.l
At all events we do not question that Brooks and Mueller
showed a relation between serum-uric-acid and the variable
they describe as " achievement orientated behaviour". Our
problem is understanding what reliable evidence led them to







New Haven, Connecticut 06510.
CAN WE PREVENT IT?
SIR May I be allowed to correct the impression given by
the statements in your leading article (Nov. 26, p. 1171) that
" death-rates from pneumonia were not demonstrably changed
by the advent of chemotherapy, any more than the upward
trend in diabetes mortality was halted by the discovery of
insulin ". In fact in both cases mortality fell substantially for
the younger age-groups. In pneumonia, death-rates for 25i34-
year-old males fell by about nine-tenths between the early
1930s and the late 1950s. By contrast pneumonia, traditionally
" the old man’s friend ", has continued to be responsible for a
growing proportion of deaths in the over-75s. A reasonable
interpretation of this pattern is that lobar and other acute
pneumonias in the young became treatable, while broncho-
pneumonia in the elderly still often fails to respond. For
diabetes in 25/34-year-old males, mortality was almost halved
between 1922 and 1932. Death-rates in the elderly, however,
started to fall only when the introduction of chemotherapy
enabled supervening infections to be controlled.
It is of course true that much of the progress towards better
health must be attributed to many factors; but in the case of
pneumonia those who attribute the greater part to " social
betterment " may find it difficult to explain why mortatity
from pneumonia in young men has fallen more than five times
1. Brooks, G. W., Mueller, E. J. Am. med. Ass. 1966, 195, 121.
